Carcinosarcoma of the ovary compared to ovarian high-grade serous carcinoma: impact of optimal cytoreduction and standard adjuvant treatment

Yalcin I., Meydanli M. M., Turan A. T., TAŞKIN S., Sari M. E., Gungor T., ...Daha Fazla

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, cilt.23, sa.2, ss.329-337, 2018 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 23 Sayı: 2
  • Basım Tarihi: 2018
  • Doi Numarası: 10.1007/s10147-017-1215-x
  • Dergi Adı: INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.329-337
  • Anahtar Kelimeler: High-grade serous ovarian cancer, Optimal cytoreductive surgery, Ovarian carcinosarcoma, Platinum, Taxane, MIXED MULLERIAN TUMORS, PROGNOSTIC-FACTORS, SURGICAL CYTOREDUCTION, CENTER EXPERIENCE, SINGLE-CENTER, CHEMOTHERAPY, PLATINUM, CANCER, PATTERNS, SURVIVAL
  • Ankara Üniversitesi Adresli: Evet

Özet

The purpose of this retrospective study was to compare the prognoses of women with ovarian carcinosarcoma (OCS) who had optimal cytoreductive surgery followed by platinum plus taxane combination chemotherapy to those of women with ovarian high-grade serous carcinoma (HGSC) treated in the same manner.